MARKET WIRE NEWS
  1. Home
  2. Stock
  3. SPRO
  4. News
SPRO
Quote
Short
News
Articles
Message Board

Spero Therapeutics Inc. (NASDAQ : SPRO ) News

Spero Therapeutics Inc. (NASDAQ: SPRO) News Releases

SPRO News Releases
SPRO : NASDAQ
SeekingAlpha
Spero Therapeutics: Tebipenem's FDA Path Supports A Speculative Buy
SPRO : NASDAQ
Investing News Network
Top 5 Small-cap Biotech Stocks of 2025
SPRO : NASDAQ
GlobeNewswire
Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis
SPRO : NASDAQ
SeekingAlpha
Spero Therapeutics GAAP EPS of -$0.13 beats by $0.12, revenue of $5.44M
SPRO : NASDAQ
GlobeNewswire
Spero Therapeutics Announces Third Quarter 2025 Operating Results and Provides a Business Update
SPRO : NASDAQ
SeekingAlpha
Here are the major earnings after the close Thursday
SPRO : NASDAQ
US Earnings Reports
Expected US Company Earnings on Thursday, November 13th, 2025
SPRO : NASDAQ
GlobeNewswire
Spero Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 13, 2025
SPRO : NASDAQ
GlobeNewswire
PIVOT-PO Phase 3 Data Show Tebipenem HBr's Potential as the First Oral Carbapenem Antibiotic for Patients with Complicated Urinary Tract Infections (cUTIs)
SPRO : NASDAQ
GlobeNewswire
Spero Therapeutics Announces Presentations on Tebipenem Hbr at IDWeek

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.